Data as of Oct 24
| +0.42 / +7.57%|
The 1 analysts offering 12-month price forecasts for SkyePharma PLC have a median target of 7.51, with a high estimate of 7.51 and a low estimate of 7.51. The median estimate represents a +25.82% increase from the last price of 5.97.
The current consensus among 1 polled investment analysts is to Buy stock in SkyePharma PLC. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.